Your Article Summary
See Latest ArticlesEconomic analysis of combined endoscopic and endobronchial ultrasound in the evaluation of patients with suspected non-small cell lung cancer
Lung Cancer, 07/01/09
Harewood GC et al. - The pre-test probability of nodal metastases can determine the most cost-effective testing strategy for evaluation of a patient with NSCLC. Pre-procedure CT may be helpful in assessing probability of mediastinal nodal metastases.
Related Articles
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 73%
Oestrogen plus progestin and lung cancer in postmenopausal women (Womens Health Initiative trial): a post-hoc analysis of a randomised controlled trial
The Lancet, 10/12/09
Relevance Score: 72%
Haplotype and Cell Proliferation Analyses of Candidate Lung Cancer Susceptibility Genes on Chromosome 15q24-25.1
Cancer Research, 10/06/09
Relevance Score: 71%
Noninvasive detection of lung cancer by analysis of exhaled breath
BMC Cancer, 10/09/09
Relevance Score: 70%
African American lung cancer patients may have different response to new cancer-fighting drugs
EurekAlert, 10/08/09
Relevance Score: 70%
Today in Diagnostic/Lung Function...keeping you current
Receive free subspecialty "5-minute updates" via email
The Use of Volumetric CT as an Imaging Biomarker in Lung Cancer
Academic Radiology, 12/08/09
HRCT Features of Small Peripheral Lung Carcinomas Detected in a Low-dose CT Screening Program
Academic Radiology, 12/08/09
Clinical utility of the QuantiFERON-TB Gold In-Tube test for the diagnosis of active pulmonary tuberculosis
Scandinavian Journal of Infectious Diseases, 12/07/09
Today in Lung/Thoracic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Lung cancer in women: the differences in epidemiology, biology and treatment outcomes
Expert Review of Respiratory Medicine, 12/08/09
The Use of Volumetric CT as an Imaging Biomarker in Lung Cancer
Academic Radiology, 12/08/09
Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer
Journal of Clinical Oncology, 12/08/09